ILANIT 2023

CLPTM1L is a novel GPI-anchoring pathway component targeted by HCMV

Inbal Kol Einat Seidel Ahmed Rishiq Shira Kahlon Ophir Pick Liat Dassa Natan Stein Ofer Mandelboim
Lautenberg Center for Immunology and Cancer Research, Hebrew University of Jerusalem, Israel

The GPI-anchoring pathway plays important roles in normal development and immune-modulation. MHC Class I Polypeptide-related Sequence A (MICA) is a stress-induced ligand, downregulated by human cytomegalovirus (HCMV) to escape immune recognition. Its most prevalent allele, MICA*008, is expressed as a GPI-anchored protein on the cell surface, via an uncharacterized pathway. Here we identify CLPTM1L (cleft lip and palate transmembrane protein 1-like protein) as a novel GPI-anchoring pathway component, and show that during HCMV infection, US9 downregulates MICA*008 via CLPTM1L. We show that the expression of other GPI-anchored proteins (CD109, CD59, and MELTF) also relies on CLPTM1L, and that like MICA*008, MELTF is downregulated by US9 via CLPTM1L during infection. Mechanistically, we show that CLPTM1L precipitates with the GPI Transamidase Complex (TAC) component PIG-T, and that PIG-T itself is important for the expression of MICA*008 and MELTF. Altogether, we report on a new GPI-anchoring pathway component which is targeted by HCMV.